학술 13-05 지역사회정신건강고위험군아동청소년의추적관리시스템구축 The development of follow-up and management system for children and adolescents at high-risk for mental health in community 발행일 2013 년 12 월 발행인하규섭 발행처국립서울병원 주소 ( 우 143-711) 서울광진구능동로 398( 구, 중곡동 30-1) 홈페이지 http://www.snmh.go.kr ISBN 978-89-951758-0-2 비매품 공공누리 출처표시 - 상업적이용금지 - 변경금 지 조건에따라이용가능.

1. 27.6%..,..,. 1), 2), 3), 4). 2. 1), 2), ()

3) 3. 1) (1) CAT(), (2) - (STAI), CoA, (K-LDES),, (K-CBCL), ADHD (ARS). 2), 9~18, 30. 3),,.,. 2,,,. 4.,.,,,,,,.

Children and Adolescents Follow-up and Management System

제 1 장서론 제 2 장연구방법 제 3 장연구결과

제 4 장기대효과및활용방안 A.

. 19 75 2011 () 25 (, ) 27.6%., 27.6%. 15.3%,,. 11.9%.. ( 1),..,,, (2011, ).

.,,,,.,. (attention-deficit/hyperactivity disorder, ADHD) 5-10%,, (American Psychiatric Association, 1994). 2005 13.3% ADHD,

2 (Seoul Child and Adolescent Metropolitan Mental Health Center, 2005). ADHD ADHD. ADHD 20-50%, (Mannuzza et al., 1993). ADHD, ADHD. Matza (2005) ADHD, ADHD 503-1,343 ADHD 4,929-5,651 1,473-2,771 2-3.,,,. 2011 ADHD 300 (Doshi, 2012). 2013 330.,. 20. 1 10-15 ~150 1. 2.64%.(Kim et al. 2011) 2-18 4.24 45%..., ASD health service $860 7.1

$6132.(Liptak GS et al., 2006), 1 47... (DSM-IV) /,.,,,,.,,. 2~16%, 18 6~16% 2~9%. 3-4.,..,,,,. 2001 40% 12.,.

(DSM-IV).... 2.7~4.6%.,,,,. 50~90%,,,.. 53%,,,..

Esquirol(1845). Weller (1986b) 1809 1982 157, DSM-III 50%, ADHD,. DSM.,,,,.,,.,

.. 1%.. 37.1%, 1 38.3% Geller(2001),,...,,,,,..,,..,,,...,. 8 10 11...

0.2-1%. 15 35,....,...

500 ICD-10 (2011) (2011, ), (F code) F32 (110, 475,920), F41 (114, 448,026), F51, (178, 237,268), F00 (213, 165,59), F45 (225, 150,931), F48 (250, 126,284), F43 (263, 116,005), F20 (288, 96,202), F33 (314, 73,941), F10, F03 (320, 72,537) F34 (326, 71,876), F90 (330, 69,450; 69,341), F31 (361, 56,668), F06, (371, 53,733), F01 (429, 36,310), F40 (449, 32,771). F00, F01, F03. 2012 1 3.. Division S.T F10 I.P Patients VisitDays 5 ~ 9 Treatment Days Treatment Amount Benefit Amount 5 5 11 141 87 - - - - -

O.P 5 5 11 141 87 S.T 24 29 144 3,365 2,088 F11~F19 I.P 3 7 8 1,181 921 F10~F29 F30~F39 F40~F48 F70~F79 F04~09, F50~59, F80~99 O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P 21 22 136 2,184 1,167 25 196 3,193 15,332 11,100 2 51 58 3,990 2,979 25 145 3,135 11,342 8,121 1,106 4,922 65,376 271,498 177,501 1 13 20 1,604 1,247 1,106 4,909 65,356 269,894 176,255 5,228 12,575 103,415 642,425 411,361 19 167 282 17,828 14,164 5,219 12,408 103,133 624,597 397,197 3,340 21,403 141,077 867,474 583,600 28 1,400 1,538 81,011 69,020 3,329 20,003 139,539 786,463 514,580 44,626 332,965 3,961,117 17,366,999 11,830,991 216 12,980 14,416 858,465 715,077 44,563 319,985 3,946,701 16,508,534 11,115,913

Division S.T Patients 10 ~ 14 VisitDays Treatment Days Treatment Amount Benefit Amount 73 81 141 7,973 4,251 F10 I.P 5 9 16 1,292 970 F11~F19 F10~F29 F30~F39 F40~F48 F70~F79 F04~09, F50~59, O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P S.T 69 72 125 6,681 3,281 86 324 1,106 34,886 24,670 32 218 261 25,381 19,767 62 106 845 9,506 4,902 358 5,624 49,955 481,830 371,223 67 2,973 3,531 238,948 189,559 344 2,651 46,424 242,882 181,664 6,538 43,490 472,533 2,798,504 1,899,698 228 7,381 9,461 664,865 506,512 6,495 36,109 463,072 2,133,639 1,393,186 11,051 37,822 351,538 2,141,646 1,414,546 169 3,199 4,174 272,803 208,601 10,981 34,623 347,364 1,868,842 1,205,945 4,137 25,724 287,702 1,436,794 989,053 53 3,305 3,699 233,673 185,218 4,122 22,419 284,003 1,203,121 803,835 50,800 444,367 7,195,896 31,127,887 21,315,520

F80~99 I.P O.P 438 18,513 23,339 1,350,187 1,049,517 50,698 425,854 7,172,557 29,777,701 20,266,003 F10 F11~F19 F10~F29 F30~F39 F40~F48 F70~F79 Division S.T I.P O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P S.T I.P O.P Patients VisitDays 15 ~ 19 Treatment Days Treatment Amount Benefit Amount 985 1,918 3,714 165,333 98,543 68 868 1,151 73,179 54,054 927 1,050 2,563 92,154 44,489 366 1,742 3,485 201,877 146,984 163 1,372 1,885 168,918 131,125 233 370 1,600 32,959 15,858 3,079 87,373 575,470 7,240,572 5,753,580 860 57,342 68,732 4,236,550 3,403,847 2,882 30,031 506,738 3,004,023 2,349,733 22,020 179,944 1,650,287 11,427,120 7,808,538 1,356 46,541 59,038 3,859,377 2,949,868 21,744 133,403 1,591,249 7,567,743 4,858,670 26,727 107,889 954,979 5,804,690 3,854,931 561 12,418 16,460 1,077,510 820,217 26,517 95,471 938,519 4,727,180 3,034,714 4,629 45,100 337,282 2,691,916 1,944,058 297 24,065 26,938 1,426,144 1,102,785 4,481 21,035 310,344 1,265,772 841,273

F04~09, F50~59, F80~99 S.T I.P O.P 28,254 234,152 3,173,695 17,433,224 12,060,172 968 50,443 59,899 3,523,897 2,669,817 27,948 183,709 3,113,796 13,909,327 9,390,355 1957 Kennedy. Principles of Preventive Psychiatry(Caplan, G: Principles of Preventive Psychiatry. NY, Basic books, Inc.,1964)...,. NIMH 1980,. (IOM) Congressional mandate..,,.(mrazek, PJ and Haggerty, RJ 1994).... (lewis's Child and Adolescent Psychiatry A Comprehensive Textbook, 4th ed)

. 4) biological factor

6 (,,,,, ) 9~15,,,

.. (IOM) Congressional mandate, (Mrazek, PJ and Haggerty, RJ 1994).,, (Indicated Preventive interventions).

(Morgan et al., 2008),,,,,,, 4,252,,.,,.,,.

Rahman 3. (Community and primary health care model),,.,,. WEE.. (Risk-taking behavior),, CDC YRBSS(Youth-Risk-taking Behavior Surveillance System). 2005 (Korea Center for Disease control and prevention),,,

.,,.,. 2013 7.2%, 2.2%. (WEE center, ),,..,,,,.,,,,.,,,, 10 ~ 18 (),,,.

New Beginnings Program-Prevention Research Program (University of Arizona) The Incredible Years Good Behavior Game Prenatal/Early Infancy Project

, HMO Genetic typing Edinburgh High Risk Study Early Psychosis Prevention and Intervention center Yale univ - Genetic testing he Alberta fetal alcohol spectrum disorder service networks (Ana et al., 2013). 2~3 (Weissman et al., 2006),,,, (Joormann, Talbot, & Gotlib, 2007). 10~20%, 2.5% mental health care (Miller, 2003).,,. (Genetic vulnerability, obstetric complications, temperament), (family functioning, care and mother-child interaction, adverse life events, coping with parental psychopathology), (poverty, social support, access to health services) (Essex et al.., 2006). 2004 ~ 2010, (Cross Sectional study, n=14), (Longitudinal study, n=16), K-SADS, Child

Behavior Check List., BDI, HAM-D/ CBQ (Ana Vilela Mendes et al., 2011). 9-10.. indicated preventive intervention Health Maintenance organization - HMO indicated preventive intervention Preventive Intervention Project(PIP) -, 8-15.

., 12%, 35~46% (Jablensky A, 1997).,,,. early child. externalizing behavior internalizing behavior. internalizing behavior externalizing behavior (Zahn-Waxler et al., 2006). New England Family Study(NEFS: 19) Providence Boston 1959 1966

17,741 prospective study, 7, 1994 2002 (Goldstein et al., 2002). 0.8% 859, 444, 212, CBCL(child Behavior check list) (Jo Ann L. et al., 2013)., 2.8, 4.4. 8.1, 3.6.,. Edinburgh High Risk Study - Early Psychosis Prevention and Intervention center -,. Yale. Selective Indicative COMT, DTNBP1, NRG1, RGS4, GRM3, DISC1, G72, DAAO.,,.

,..,,,. feedback,,.,, (Velleman R et al., 2007).,,,. K-ARS ADHD Rating Scale-IV (Dupal et al, 1998) / O

K-CASS Conners-Wells (CASS ; Conners & Well, 1985) O BDI - (BDI) O RCMAS (Revissed Children's Manifest Anxiety Scale; RCMAS, Reynolds & O Richmonde 1979, 1985) ESI (Eppendorf Schizoprhrenia Inventory) O RSIQ (Reynold, 1987) O SCT (Sentence Completion Test) K-CBCL (Korean Child Behavior Checklist) O K-PIC (Korean Personality Inventory for child) O K-YSR (K-YSR) O MMPI-A (Adolescent Minnesota Multiphasic Inventory) O K-WISC (Korean Wechsler Intelligence Scale for Children) O SCL-90-R (Symptom Checklist -op-revision) O K-DISC-IV (Diagnostic Interview Schedule for Children Version) O CAT (Comprehensive Attention Test) O K-LDES (Korean version of Learning Disability Evaluation Scale) O STAI O CAST-K CoA (The korean version of the Children of the Children fo Alcoholics Screening Test) O - K-DISC-IV (Diagnostic Interview Schedule for Children Version) : DSM-IV ICD-10,.

:,. :,,,,, (,,,, ) : (2007),. :,,,. - K-SAD-PL (Kiddle Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version) : ADHD, : Kim YS et al.(2004) ADHD,, -, :,,,,,,. - MMPI-A (Minnesota Multiphasic Personality Inventory - Adolescent) : Sherwood, Ben Porath Williams(1997). : 15 13 31 478,,,. : 13 ~18, 0.54, 0.58. 40-90.

- K-PIC (Korean Personality Inventory for Children) : (1997) Wirt(1958) PIC(Personality Inventory for Children), : 6,,,,,. 1), 2), 3), 4), 5) 6)..,,,,.,,,. < 10 >

1 - (STAI) 2 CoA (CAT) 1 2 (K-CBCL) 3 ADHD (K-ARS) 4 (K-LDES) Happy mind., (ADHD). 6 1) (), 2) (), 3), 4), 5), 6). //,. ( ) ( ), ( ).,.

Achenbach 1983. (1990). K-CBCL 15~20,. 1991 CBCL(Achenbach).,,,,. 119 3.,. K-CBCL. Spielberger(1972) (1989). 20,?,?. 0~3 0 60. 39~42, 43~46, 49.

ADHD DuPaul(1997). K-ARS DSM-Ⅳ ADHD 18. 0, 1, 2, 3. -. Jones(1983), (1995),, 30.,,,,,,.. 94 42 88,. 7 -,,,,,, -. 10(=3)

, 7 7 (Learning Quotient; LQ). 100 15.. 1,,.

6 9~18 30.

no. () 1 F 40~49 2 M 40~49 3 F 50~59 4 F 40~49 5 M 40~49 6 F 40~49 7 F 40~49 8 M 30~39 9 M 30~39 10 M 30~39 11 M 50~59 12 F 50~59 13 M 40~49 14 M 40~49 15 M 40~49 16 M 40~49 17 F 40~49 18 F 40~49 19 F 60~69 20 M 40~49 21 M 40~49 22 M 40~49 23 F 40~49 24 F 40~49 25 M 40~49 26 M 40~49

27 F 40~49 28 M 40~49 29 F 40~49 30 F 40~49. CAT().,. 2013 11 01 ~ 12 30.,..

1) SPSS 20.0.,,,,. ADHD,,,,,,,,. Kruskal-wallis test, p-value (p-value<.05).

2) (1) N=30 (N=13) N(%) (N=12) N( %) (N=3) N(%) (N=2) N(%) 9(69.2) 4(30.8) 13.92 (1.89) 0(.0) 0(.0) 3(23.1) 3(23.1) 7(53.8) 9(69.2) 0(.0) 1(7.7) 6(50.0) 6(50.0) 13.92 (2.19) 0(.0) 0(.0) 0(.0) 5(41.7) 7(58.3) 1(8.3) 2(16.7) 3(25.0) 2(66.7) 1(33.3) 15.33 (3.21) 0(.0) 0(.0) 0(.0) 1(33.3) 2(66.7) 1(33.3) 0(0) 0(0) 1(50.0) 1(50.0) 16.50 (.71) 0(.0) 0(.0) 0(.0) 0(.0) 2(100.0) 2(100.0) 0(.0) 0(.0) 3(23.1) 6(50.0) 2(66.7) 0(.0) 3.25(.60) 3.24(.41) 3.02(.64) 4.38(.60) 2(16.7) 9(75.0) 1(8.3) 1(8.3) 8(66.7) 3(25.0) 1(33.3) 2(66.7) 0(.0) 2(100.0) 0(.0) 0(.0) 6(46.2) 0(.0) 7(53.8) 6(50.0) 4(33.3) 2(16.7) 2(66.7) 1(33.3) 0(.0) 0(.0) 0(.0) 2(100.0)

(2) N (%) N (%) ADHD (19 ) 22(71.0) 8(25.8) 30(100.0) N (%) N (%) N (%) N (%) (20-40: 41-44: 45-48: 49 : ) 28(93.3) 1(3.3) 0(.0) 1(3.3) 30(100.0) (20-38: 39-42: 43-46: 47 : ) 26(86.7) 2(6.7) 1(3.3) 1(3.3) 30(100.0)

(63 ) (63 ) (63 ) / (70 ) / (70 ) (70 ) (70 ) (60 ) (63 ) (70 ) (70 ) (70 ) (70 ) (70 ) (70 ) N (%) N (%) N (%) 17(56.7) 17(56.7) 30(100.0) 13(43.4) 13(43.4) 30(100.0) 18(60.0) 12(40.0) 30(100.0) 26(86.7) 4(13.3) 30(100.0) 21(70.0) 9(30.0) 30(100.0) 25(83.3) 5(16.7) 30(100.0) 22(73.3) 8(26.7) 30(100.0) 25(83.3) 5(16.7) 30(100.0) 18(60.0) 12(40.0) 30(100.0) 25(83.3) 5(16.7) 30(100.0) 27(90.0) 3(10.0) 30(100.0) 24(80.0) 6(20.0) 30(100.0) 30(100.0) 0(.0) 30(100.0) 29(96.7) 1(3.3) 30(100.0) 30(100.0) 0(.0) 30(100.0)

N(%) N(%) N(%) 22(73.3) 24(80.0) 19(63.3) 8(26.7) 6(20.0) 11(36.7) 30(100.0) 30(100.0) 30(100.0) - 30 60%, 40%, 14.92, 60%, 43.3%, 3.47kg. 63.3%, 53.3%. < 12>. - ADHD (K-ARS) 19 8(25.8%), 2 (6.7%), 4 (13.3%). - (K-CBCL) (17, 56.7%), (13, 43.4%), /(12, 40.0%). - (CAT).

(2) N=30 (N=13) Mean (SD) (N=12) Mean (SD) (N=3) Mean (SD) 4.85(1.78) 8.83(7.42) 14.67(5.508) (N=2) Mean (SD) 3.50(3.536) 3.23(6.58) 5.75(5.36) 8.33(6.03) 3.00(1.41) 8.08(12.76) 14.58(12.32) 23.00(11.53) 6.50(4.950) N=30 (N=13) Mean (SD) (N=12) Mean (SD) (N=3) Mean (SD) (N=2) Mean (SD) 32.69(4.70) 33.42(9.48) 36.67(5.69) 29.00 32.54(7.50) 32.25(5.08) 29.67(7.57) 27.50(7.78) N=30 (N=13) Mean (SD) (N=12) Mean (SD) (N=3) Mean (SD) (N=2) Mean (SD) 7.92(5.58) 5.25(6.48) 4.67(4.93) 11.50(7.78)

N=30 (N=13) Mean (SD) (N=12) Mean (SD) (N=3) Mean (SD) 59.31(19.60) 66.67(11.18) 54.67(13.05) (N=2) Mean (SD) 55.00(7.07) 60.38(15.13) 67.75(10.22) 60.67(6.03) 50.50(4.95) 62.23(16.26) 59.67(10.47) 52.33(5.03) 54.50(6.36) / 62.62(15.15) 62.00(7.17) 55.00(14.11) 55.00(1.41) / 58.92(21.78) 69.58(9.40) 65.33(10.60) 55.00(7.07) 53.77(20.47) 63.07(9.36) 60.00(6.25) 50.00 60.00(20.43) 65.42(12.69) 61.33(12.34) 66.00(7.07) 63.69(18.79) 62.17(7.84) 46.00(17.78) 52.00(2.83) 53.38(23.45) 61.83(10.26) 45.33(28.89) 57.50(10.61) 64.46(17.23) 59.58(9.52) 48.67(15.37) 55.50(7.78) 59.00(16.60) 58.08(15.30) 53.33(4.16) 55.00(4.24) 53.62(19.95) 63.67(12.54) 52.67(20.13) 53.30(4.95) 37.23(19.76) 38.00(11.99) 21.67(18.61) 46.50(20.51) 38.08(22.35) 37.33(9.30) 31.33(19.22) 51.00(12.73) 41.31(18.74) 43.92(14.29) 20.00(17.31) 42.50(20.51)

N=30 (N=13) Mean (SD) (N=12) Mean (SD) (N=3) Mean (SD) 8.23(1.48) 11.33(3.87) 12.33(4.73) (N=2) Mean (SD) 9.50(2.12) 20.08(5.94) 25.92(7.28) 29.00(11.14) 19.00(14.14) 10.85(2.70) 12.83(4.15) 12.67(2.52) 12.00(1.41) 16.85(4.36) 19.25(5.31) 25.67(4.93) 21.50(4.95) * 16.46(5.17) 18.17(4.15) 25.67(5.69) 19.50(3.54) 8.85(2.51) 10.75(3.67) 12.00(1.73) 10.50(3.54) * 23.15(5.43) 25.58(4.80) 37.33(12.10) 36.00(18.39)

N=30 (N=13) Mean (SD) (N=12) Mean (SD) (N=3) Mean (SD) (N=2) Mean (SD) 98.00(10.62) 90.50(29.56) 103.67(4.16) 91.50(16.23) 99.31(10.40) 93.33(16.20) 100.33(9.07) 74.50(40.31) 94.08(7.92) 90.67(12.48) 89.67(10.21) 84.00(14.14) 92.08(23.05) 91.92(17.94) 86.33(24.58) 60.00(60.81) 103.08(7.71) 105.42(5.42) 104.00(3.61) 94.50(6.36) 100.54(10.71) 98.92(11.12) 99.00(4.58) 88.50(19.09) 90.77(11.92) 94.50(12.88) 100.00(7.81) 82.00(12.73) 97.08(17.34) 99.25(16.97) 110.33(7.77) 81.00(28.28) 98.62(18.40) 100.25(5.05) 102.67(3.51) 55.50(68.59) 95.54(18.70) 93.33(15.41) 84.00(12.50) 85.50(26.16) 99.38(7.45) 95.25(13.04) 102.33(9.30) 90.00(12.73) 100.23(20.02) 96.58(12.69) 104.33(5.51) 79.00(35.36) 94.69(28.58) 84.64(29.21) 101.67(2.08) 92.50(12.02) 89.85(12.02) 97.73(16.06) 88.67(12.42) 87.50(14.85)

90.38(10.11) 79.55(15.19) 91.00(14.00) 51.50(57.28) 89.15(28.59) 80.36(25.62) 98.67(9.24) 51.50(70.00) 86.46(33.80) 97.64(14.49) 89.67(10.69) 93.00(21.21) 91.46(23.09) 99.91(9.88) 97.00(18.25) 94.00(15.56) 89.08(19.18) 87.55(16.62) 95.67(11.93) 62.00(36.77) 100.33 89.08(30.80) 87.73(10.82) (13.87) 73.50(36.06) 98.62(19.94) 104.45 98.67(19.43) 84.00(45.26) (18.24) 96.00(16.30) 102.18 88.33(18.23) 92.00(55.15) (14.69) 94.62(14.14) 100.55(9.10) 80.33(6.81) 87.00(56.57) 93.77(14.48) 101.36(8.13) 85.67(2.31) 87.00(57.98) - N (Median), (p<.05) (K-LDES). < 21>.,.

,.,,.,,, caregiver,.,,,.,,.,, 2 step,., /.,,,,.,,,,.,,,,

,. 1) (follow-up loss).,.,,,,.,,,..,,,,..,,.,.

2).,, /, WEE ( ),, /,, /.,,. 3) 1, 2,,,,.,, 1 1/2,,.,,,,.,,, stigma,,,..

, //,,..,, Wee.,,,,,,,.,.,,,. 4), (1),,,.,,,.,,,

,, ().,,.,,. (2),,.,, (5 ~ 9 /10 ~ 15/16 ~ 18),. (3),,..,,.,,,,,,.

5) (1) A. 1 :,,.,,,,,. 12%, 35~46%.,,,., marker.,,,,., 1,,, K-SADS-PL-K (Kiddie-Schedule for Affective disorders and Schizophrenia-Present and Lifetime Version-Korean version, Kim et al, 2004),. ADHD (ARS), - (STAI)., CoA,.

B. 2 :,,,,,, (Comprehensive Attention Test: CAT), (Korean version of Learning Disability Evaluation Scale: K-LDES), (K-Child Behavior Check List: K-CBCL).,,,, ().,. (2) 1, 2. 1 3 1,.,,, (,,, ),,. ( ),,.,,, 3 1, 1, K-SADS-PL-K/K-DISC-IV 1,. ( )

. (3).,,.,.,..,,., ().,,. 6),,,,,,,.,,,

,., feedback,,,,.,., 3~5,,,,,.

부모용설문지 대상자식별번호 대상자이니셜 평가자성명 환경요인에대한노출평가 아동에대한깊이있는이해를위해서자세하게문항을만들었습니다. 해당사항을고를때는그아동에게가장적합한문장에표시를하시면됩니다. 가능하면모든사항을빼놓지않고기술해주십시오. 기록하는사람 : 1. 어머니 아버지 3. 기타 누구? ) 기록하는날짜 년월일 [ 출산 ] 1. 어린이는달수를다채우고출생하였습니까?: 조산아 ( 주수 : 주 ) 정상아 과숙아 ( 주수 : 주 ) 모름 2. 출산방식 : 정상질식분만 기계사용 ( 예 : 감자분만, 흡입기사용등 ) 유도분만 제왕절개 제왕절개라면, 계획된것? 이유? 응급제왕절개? 이유? 3. 출산시다음의문제가있었습니까? ( 있었던것만표시하여주세요 ): 난산 (14 시간이상의분만시간 ) 이유는? 분만동안심폐기능의이상? 목에탯줄이감긴채로분만?

아이가분만후호흡곤란, 청색증, 산소결핍이있었다? 태반문제 구체적으로기술 탯줄문제 구체적으로기술 태아문제 구체적으로기술 기타 ( 자세히기술하여주십시오 ) 4. 출생시어린이의체중 : kg 5. 출생후인큐베이터에있어야했습니까?: 예 아니오 있었다면이유? 6. 출생후어린이에게신체적인문제가있었습니까 ( 예 : 심한황달, 경련, 선천성기형장애등 )?: 예 아니오있었다면구체적으로 7. 어머니가분만전혹은분만후우울한기분을지속적으로 ( 한달이상 ) 경험하 였습니까? 그렇다면 : 1 2 3 4 5 경함 매우심함 모르겠다 [ 흡연력 ] 1. 해당자녀가거주하는집에서담배를피우는사람이있습니까? 피우는사람이전혀없다. 집안에서담배를피운다. 베란다등실외에서피운다. (" 피우는사람이전혀없다 " 라고답하셨다면음주력문항으로가시고, " 집안에서담배를피운다 " 또는 " 베란다등실외에서피운다 " 라고답하신분들은 1-1번문항으로가십시오 )

1-1. 해당자녀가거주하는집에서흡연자는몇명입니까? 명 1-2. 해당자녀가거주하는집에서흡연자가피우는담배는총몇개피입니까? 개피 / 하루 1-3. 해당자녀가거주하는집에서실내의담배연기정도는어떠합니까? 거의없음 희미 보통 자욱 대단히자욱 1-4. 해당자녀가평균적으로담배연기에노출되는시간은어떠합니까? 하루에 시간, 일주일에 일

부모용설문지 피험자식별번호 피험자이니셜 평가자성명 ADHD 평정척도 (ARS) * 다음질문들은당신의자녀에관한것입니다. 당신의자녀가지난 1주일동안 집안에서보인행동을가장잘기술한번호에동그라미치십시오. 전혀약간상당히매우그렇지혹은혹은자주않다가끔자주그렇 ( 매우그렇다그렇다다드물다 ) 1. 학교수업이나일, 혹은다른활동을할때, 주의집중을하지않고부주의해서실수를많이한다. 0 1 2 3 2. 가만히앉아있지를못하고손발을계속움직이거나몸을꿈틀거린다. 0 1 2 3 3. 과제나놀이를할때지속적으로주의집중하는데어려움이있다. 0 1 2 3 4. 수업시간이나가만히앉아있어야하는상황에서자리에서일어나돌아다닌다. 0 1 2 3 5. 다른사람이직접이야기하는데에도잘귀기울여듣지않는것처럼보인다. 0 1 2 3 6. 상황에맞지않게과도하게뛰어다니거나기어오른다. 0 1 2 3 7. 지시에따라서학업이나집안일이나자신이해야할일을끝마치지못한다. 0 1 2 3 8. 조용히하는놀이나오락활동에참여하는데어려움이있다. 0 1 2 3 9. 과제나활동을체계적으로하는데어려움이있다. 0 1 2 3 10. 항상 끊임없이움직이거나 마치 모터가달려서움직이는것처럼 행동한다. 0 1 2 3 11. 공부나숙제등, 지속적으로정신적노력이필요한일이나활동을피하거나싫어하거나또는하기 0 1 2 3

를꺼려한다. 12. 말을너무많이한다. 0 1 2 3 13. 과제나활동을하는데필요한것들 ( 장난감, 숙제, 연필등 ) 을잃어버린다. 0 1 2 3 14. 질문을끝까지듣지않고대답한다. 0 1 2 3 15. 외부자극에의해쉽게산만해진다. 0 1 2 3 16. 자기순서를기다리지못한다. 0 1 2 3 17. 일상적인활동을잊어버린다. ( 예 : 숙제를잊어버리거나도시락을두고학교에간다 ) 0 1 2 3 18. 다른사람을방해하고간섭한다. 0 1 2 3

학생용설문지 피험자식별번호 피험자이니셜 평가자성명 소아용상태 - 특성불안평가척도 (STAI) 1. 1 2. 3. 2. 1. 2. 3. 3. 1. 2 3. 4. 1. 2. 3. 5. 1. 2. 3. 6. 1. 2 3. 7. 1 2. 3. 8. 1. 2. 3. 9. 1. 2. 3. 10. 1 2. 3. 11. 1. 2. 3. 12. 1. 2. 3. 13. 1. 2. 3. 14. 1. 2. 3. 15. 1. 2. 3. 16. 1. 2. 3. 17. 1. 2. 3. 18. 1. 2. 3. 19. 1. 2. 3. 20. 1. 2 3.

1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20.

학생용설문지 피험자식별번호 피험자이니셜 평가자성명 한국어판 CoA 선별검사 (The Korean Version of Children of Alcoholics Screening Test: CAST-K)

2011,, II (2012), 2013.. 2012, https://yhs.cdc.go.kr/. K-SADS-PL. :, 2003.., :, 2012.,,. :,, 1995 34(4): 1182-1193.,., 2013.,, " ",, 14, 3, pp.150-157, 1989. Achenbach TM, Edelbrock C. Manual for the child behavior checklist/ 4-18 and 1991 profile. Burlington: University of Vermont;1991.

Beardslee WR et al. A family-based approach to the prevention of depressive symptoms in children at risk: evidence of parental and child change. Pediatrics. 2003 Aug;112(2):e119-31. Biederman J, Faraone SV, Doyle A, Lehman BK, Kraus I, Perrin J, et al. Convergence of the Child Behavior Checklist with structured interviewbased psychiatric diagnoses of ADHD children with and without co-morbidity. J Child Psychol Psychiatry 1993;34:1241-1251. Bondy B et al. Genetics of suicide. Mol Psychiatry. 2006 Apr;11(4):336-51. C. D. Spielberger, Manual for the State-Trait Anxiety Inventory for Children, Palo Alto, Consulting Psychologist Press, 1972. Cho SC, Kim BN, Kim JW, Kim HW, Choi HJ, Jung SW, et al. The reliability and validity of Diagnostic Interview Schedule for Children Version IV-Korean version (DISC-IV). J Kor Acad Child Adolesc Psychiatry. In Press 2007. Clarke GN et al. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001 Dec;58(12):1127-34. Clarke GN et al. Group cognitive-behavioral treatment for depressed adolescent offspring of depressed parents in a health maintenance organization. J Am Acad Child Adolesc Psychiatry. 2002 Mar;41(3):305-13.

Eckenrode J et al. Long-term effects of prenatal and infancy nurse home visitation on the life course of youths: 19-year follow-up of a randomized trial. Arch Pediatr Adolesc Med. 2010 Jan;164(1):9-15. Ha EH, Oh KJ, Hong KE, Lee HL. Reconstruction of the behavior problem scales of the Korean CBCL. The Seoul J of Psychiatry 1996;20:45-52. Hanik K. Yoo, M.D., Ph.D.1), Jungsun Lee, M.D. et al., Standardization of the Comprehensive Attention Test for the Korean Children and Adolescents. J Kor Acad Child Adolesc Psychiatry 2009;20:68-75. Hong KE, Song HH, Kim ZS, Hong KJ, Park SS. An epidemiological study of behavior problems in Korean elementary school children by CBCL. J Korean Neuropsychiatr Assoc 1988;27:346-358. Johnstone EC et al. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry. 2005 Jan;186:18-25. Kellam SG, Anthony JC. Targeting early antecedents to prevent tobacco smoking: findings from an epidemiologically based randomized field trial. Am J Public Health. 1998 Oct;88(10):1490-5. Kleinman JE et al. Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry. 2011 Jan 15;69(2):140-5.

Kim YS, So YK, Noh JS, Choi NK, Kim SJ, Koh YJ. Normative data on the Korean ADHD Rating Scales (K-ARS) for parents and teacher. J Korean Neuropsychiatr Assoc 2003;42:352-359. Liptak GS et al. Health care utilization and expenditures for children with autism: data from U.S. national samples. J Autism Dev Disord. 2006 Oct;36(7):871-9. Mann JJ et al. Suicide prevention strategies: a systematic review. JAMA. 2005 Oct 26;294(16):2064-74. Review. McGorry PD et al. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. J Clin Psychiatry. 2013 Apr;74(4):349-56. Meltzer H. Gatward R, Goodman R, Ford T. Mental health of Children and Adolescents in Great Britain. London: The Stationery Office, 2000. Mrazek, PJ and Haggerty, RJ (eds.) : Institute of medicine:reducing Risks for Mental Disorders:Frontiers for Preventive Intervention Research. Washington, DC, National Academy Press, 1994. Oh KJ, Lee HL. Development of korean child behavior checklist: a preliminary study. J Korean Neuropsychiatr Assoc 1990;29:452-462. So YK, Noh JS, Kim YS, Ko SG, Koh YJ. The reliability and validity of

Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc 2002;41:283-289. Thanh NX et al. Potential impacts of the Alberta fetal alcohol spectrum disorder service networks on secondary disabilities: a cost-benefit analysis. J Popul Ther Clin Pharmacol. 2013;20(2):e193-200. Remschmidt H. Belfer M. Mental health care for children and adolescents Worldwide: A review. World Psychiatry, 2005, 4:3:147-153. Webster-Stratton C, Reid MJ, Hammond M.J. Preventing conduct problems, promoting social competence: a parent and teacher training partnership in head start.clin Child Psychol. 2001 Sep;30(3):283-302. Wolchik SA, et al. Fifteen-year follow-up of a randomized trial of a preventive intervention for divorced families: Effects on mental health and substance use outcomes in young adulthood. J Consult Clin Psychol. 2013 Aug;81(4):660-73. Woods SW et al. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry. 2003 Aug 15;54(4):453-64.